Welcome to the international HTA database

Showing [23371 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[The clinical effectiveness and economic analysis of bariatric surgery for severe obesity]
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Appraisal of the quality and accuracy of written consumer health information for patients with chronic myeloid leukaemia on treatment-regimens with dasatinib, imatinib or nilotinib
2012	HAYES, Inc.	Interferon-gamma release assays for tuberculosis
2012	NIHR Horizon Scanning Centre (NIHR HSC)	GSK-2402968 (Drisapersen) for duchenne muscular dystrophy – first line
2012	HAYES, Inc.	Radioactive seed localization (RSL) of nonpalpable breast lesions for surgical excision
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Economic evaluation of single tooth replacement: dental implant vs. bridge]
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Axitinib for 2nd-line metastatic renal cell carcinoma
2012	HAYES, Inc.	Lee Silverman voice treatment for speech and voice problems in parkinson's disease
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Ustekinumab (Stelara) for psoriatic arthritis
2012	HAYES, Inc.	Statscan critical imaging system (Lodox Systems (Pty) Ltd.) for evaluation of patients with trauma or injury
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study of high-risk dyslipidemia for cardiocerebrovascular disease in Koreans]
2012	HAYES, Inc.	Mannitol bronchial provocation challenge for asthma
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for moderate to severe, active rheumatoid arthritis
2012	HAYES, Inc.	VeinViewer (Christie Digital Systems USA Inc.) for guiding venous access procedures in children
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Assessment of the effectiveness of sublingual immunotherapy and subcutaneous immunotherapy in allergic rhinitis and asthma]
2012	HAYES, Inc.	Occipital nerve stimulation for chronic cluster headache and chronic migraine headache
2012	NIHR Horizon Scanning Centre (NIHR HSC)	EPI-743 for mitochondrial disease – first line
2012	HAYES, Inc.	Negative pressure wound therapy for postsurgical mediastinitis
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[The clinical usefulness and cost-effectiveness of CT coronary angiography for the diagnosis of ischemic heart disease in patients with chest pain]
2012	HAYES, Inc.	Mosaicplasty
2012	NIHR Horizon Scanning Centre (NIHR HSC)	BIIB-017 for relapsing forms of multiple sclerosis
2012	HAYES, Inc.	Negative pressure wound therapy for wounds other than sternal wounds and skin grafts
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Small study effect and publication bias in systematic reviews with meta-analyses]
2012	HAYES, Inc.	Palivizumab (Synagis®) prophylaxis for respiratory syncytial virus infection in preterm infants
2012	Adelaide Health Technology Assessment (AHTA)	Genetic testing for the diagnosis or prediction of Long QT Syndrome
2012	HAYES, Inc.	Negative pressure wound therapy in the adjunct treatment of skin grafts
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Utilization patterns and comparative effectiveness of inhaled bronchodilators/corticosteroids for patients with chronic airway diseases]
2012	HAYES, Inc.	Percutaneous kyphoplasty
2012	HAYES, Inc.	Pharmacokinetically guided dose adjustment of 5-fluorouracil (5-FU)
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A research on evidence-based healthcare for thyroid cancer screening: Part 2: Effectiveness of ultrasonographic screening for thyroid cancer]
2012	HAYES, Inc.	Percutaneous vertebroplasty
2012	Andalusian Health Technology Assessment Area (AETSA)	[Protease inhibitors (Boceprevir and telaprevir) in the treatment of chronic HCV infection: relative efficacy, safety and efficiency]
2012	HAYES, Inc.	Radiofrequency ablation for sacroiliac joint pain
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Evaluating the health service and inequality in the health insurance coverage expansion for cancer; Before and after study: Part 1: Evaluation of the change in medical services before and after the enhancement of health insurance coverage of cancer]
2012	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in lung cancer
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Palliative care requirements in the case of non-oncological diseases. A qualitative study from the perspective of professionals, patients and carers`]
2012	National Institute for Health and Care Excellence (NICE)	PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites. NICE medical technologies guidance 9
2012	HAYES, Inc.	Telerehabilitation for musculoskeletal conditions, neuromuscular conditions, and mobility impairment
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: Amniotic fluid lactate™ monitoring system for dysfunctional labour
2012	HAYES, Inc.	Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Evaluating the health service and inequality in the health insurance coverage expansion for cancer; Before and after study: Part 2: Evaluation of the impact in inequality before and after the enhancement of health insurance coverage of cancer]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Multicentre study to analyse the effectiveness of telemedicine in spirometry quality assurance programmes]
2012	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Routine use of CYP-test in antipsychotic drug treatment - a health technology assessment]
2012	HAYES, Inc.	Topical antiseptic products for preoperative skin preparation
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for severe asthma
2012	HAYES, Inc.	Sialoendoscopy for salivary gland stones
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on current research status of psychiatric disorders, depression and suicide in Korea: Part Ⅰ. A study on current status and unmet need for the treatment of psychiatric disorders in Korea]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease]
2012	Technology Assessment Unit of the McGill University Health Centre (MUHC)	The clinical effectiveness and cost of a pneumococcal urine antigen immunochromatographic test (BinaxNOW Streptococcus pneumoniae) in the diagnosis of community acquire Streptococcus pneumoniae pneumonia in patients admitted to hospital
2012	HAYES, Inc.	Transcatheter aortic valve implantation for aortic stenosis
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Omalizumab for chronic spontaneous urticaria – second line
2012	HAYES, Inc.	Vision therapy for dyslexia and other reading and learning disabilities
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on current research status of psychiatric disorders, depression and suicide in Korea: Part Ⅱ. Study on adolescent depression and suicide]
2012	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Hyperbaric oxygen treatment of injuries after radiotherapy for head and neck cancer - a health technology assessment]
2012	HAYES, Inc.	Ultrasound-guided injections of joints of the extremities
2012	HAYES, Inc.	Vitamin D supplementation in patients with osteoporosis
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on current research status of psychiatric disorders, depression and suicide in Korea: Part Ⅲ. A study on the current status and treatment promotion of comorbid depression among patients with cancer or patients with diabetes mellitus]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Contaminants from the treatment of drinking water in the Autonomous Community of the Basque Country: Assessment of the risk and alternative treatments]
2012	HAYES, Inc.	Whole body vibration for the promotion of bone growth in postmenopausal women
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A research on evidence-based healthcare for thyroid cancer screening: Part 1: the current status of thyroid cancer screening]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: OVA1™ test for the assessment of suspected ovarian cancer
2012	HAYES, Inc.	Complement factor H (CFH) p.Tyr402His and age-related maculopathy susceptibility 2 (ARMS2) p.Ala69Ser polymorphism testing for susceptibility to age-related macular degeneration (AMD)
2012	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of genetic tests for screening of colorectal cancer]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Cost evaluation of the early breast cancer detection programme of the Autonomous Community of the Basque Country]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: Xpert MTB/RIF® test for tuberculosis
2012	HAYES, Inc.	Cytochrome P450 21A2 (CYP21A2) testing in congenital adrenal hyperplasia
2012	Agency for Healthcare Research and Quality (AHRQ)	Skin substitutes for treating chronic wounds
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Therapeutic strategies in refractory schizophrenia or treatment resistant schizophrenia]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: RealTime mS9 Colorectal Cancer (CRC) Assay for the early detection of colorectal cancer
2012	HAYES, Inc.	Factor V (F5) HR2 haplotype testing for hypercoagulability
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Anti-angiogenic drugs in the treatment for age-related macular degeneration: issues associated with their use in Québec]
2012	Agency for Healthcare Research and Quality (AHRQ)	Management of asymptomatic carotid stenosis
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Validation of a malnutrition screening tool useful in a general hospital]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) in combination with trastuzumab and chemotherapy for HER2-positive, node-positive or high risk node-negative breast cancer – adjuvant therapy
2012	HAYES, Inc.	Factor VII (F7) p.Arg353Gln polymorphism testing
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Sentinel lymph node biopsy in breast cancer treatment: indications and contraindications]
2012	Health Information and Quality Authority (HIQA)	Economic evaluation of repeat universal antenatal screening for HIV in the third trimester of pregnancy
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Telemonitoring in patients with heart failure or chronic obstructive disease. Systematic review of the literature]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Everolimus (Afinitor) with trastuzumab and paclitaxel for HER2 positive locally advanced or metastatic breast cancer – first line
2012	HAYES, Inc.	Factor XIIIA1 (F13A1) p.Val34Leu polymorphism testing
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Overview of the use of antihypertensive agents by adults covered by the Québec public prescription drug insurance plan]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Budget impact analysis of a telemedicine procedure in quality assurance programs for spirometry in patients with COPD]
2012	NIHR Health Technology Assessment programme	Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Farletuzumab for ovarian cancer: relapsed, platinum-sensitive – in combination with carboplatin and a taxane
2012	HAYES, Inc.	KRAS sequence variant analysis for predicting response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the treatment of non-small cell lung cancer (NSCLC)
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Complications associated with the surgical instruments used in tonsillectomies]
2012	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Innovative medical devices for diabetes management
2012	NIHR Horizon Scanning Centre (NIHR HSC)	NGR-TNF for malignant pleural mesothelioma – second line
2012	HAYES, Inc.	Ryanodine receptor 1 (RYR1) testing for malignant hyperthermia susceptibility (MHS)
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Description of the use of Proton Pump Inhibitors (PPIs) in adults covered by the public prescription drug insurance plan]
2012	NIHR Health Technology Assessment programme	Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study)
2012	The Netherlands Organisation for Health Research and Development (ZonMw)	[Implementation of a multiple intervention aimed at optimising prescription of antibiotics for respiratory tract infections, embedded within the new practice accreditation of the Dutch College of General Practitioners; a randomized controlled trial]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Nintedanib (Vargatef) for epithelial ovarian, fallopian tube or primary peritoneal carcinoma: advanced (stage IIB-IV) – first or second line; in combination with carboplatin and paclitaxel following initial surgery, where indicated
2012	HAYES, Inc.	Septin 9 (SEPT9) methylation analysis for colorectal cancer
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Diagnosis and treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in people with Multiple Sclerosis (MS)]
2012	HAYES, Inc.	Alair bronchial thermoplasty system for treatment of asthma
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Diagnosis and consumption of drugs for Alzheimer's disease in the Basque country]
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Panobinostat (Faridak) for relapsed or refractory multiple myeloma
2012	HAYES, Inc.	TP63-related disorders (ectrodactyly-ectodermal dysplasia-clefting [EEC3] syndrome; acro-dermato-ungual-lacrimal-tooth [ADULT] syndrome; ankyloblepharon-ectodermal dysplasia-clefting [AEC; hay-wells] syndrome; limb-mammary syndrome (LMS); nonsyndromic split-hand/split-foot malformation [SHFM4]; rapp-hodgkin syndrome [RHS])
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Organization and provision of rehabilitation services for stroke patients and their families: a review of the evidence]